Tandem Diabetes Care, Inc. (TNDM)
TNDM Stock Price Chart
Explore Tandem Diabetes Care, Inc. interactive price chart. Choose custom timeframes to analyze TNDM price movements and trends.
TNDM Company Profile
Discover essential business fundamentals and corporate details for Tandem Diabetes Care, Inc. (TNDM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
14 Nov 2013
Employees
2.65k
Website
https://www.tandemdiabetes.comCEO
John F. Sheridan
Description
Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based application that visually presents diabetes data from the pump, continuous glucose monitoring (CGM) devices, and supported blood glucose meters to patients, their caregivers, and healthcare professionals. Additionally, the Sugarmate mobile application caters specifically to insulin users with diabetes. Tandem has strategic development and commercialization partnerships with leading companies such as Dexcom, Inc. and Abbott Laboratories. Established in 2006 and headquartered in San Diego, California, the company was initially known as Phluid Inc. before rebranding as Tandem Diabetes Care, Inc. in January 2008.
TNDM Financial Timeline
Browse a chronological timeline of Tandem Diabetes Care, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.34, while revenue estimate is $255.01m.
Earnings released on 7 May 2026
EPS came in at -$0.30 surpassing the estimated -$0.46 by +34.78%, while revenue for the quarter reached $247.22m , beating expectations by +2.83%.
Earnings released on 19 Feb 2026
EPS came in at -$0.01 surpassing the estimated -$0.05 by +80.00%, while revenue for the quarter reached $290.38m , beating expectations by +4.83%.
Earnings released on 6 Nov 2025
EPS came in at -$0.31 matching the estimated -$0.31, while revenue for the quarter reached $249.25m , missing expectations by -10.00%.
Earnings released on 6 Aug 2025
EPS came in at -$0.48 falling short of the estimated -$0.40 by -20.00%, while revenue for the quarter reached $240.68m , missing expectations by -3.81%.
Earnings released on 30 Apr 2025
EPS came in at -$0.67 falling short of the estimated -$0.60 by -11.67%, while revenue for the quarter reached $234.42m , beating expectations by +6.45%.
Earnings released on 26 Feb 2025
EPS came in at -$0.44 falling short of the estimated -$0.25 by -76.00%, while revenue for the quarter reached $282.65m , beating expectations by +12.43%.
Earnings released on 6 Nov 2024
EPS came in at -$0.36 surpassing the estimated -$0.43 by +16.28%, while revenue for the quarter reached $363.29m , beating expectations by +44.45%.
Earnings released on 1 Aug 2024
EPS came in at -$0.47 surpassing the estimated -$0.54 by +12.96%, while revenue for the quarter reached $221.91m , beating expectations by +8.30%.
Earnings released on 2 May 2024
EPS came in at -$0.63 surpassing the estimated -$0.80 by +21.25%, while revenue for the quarter reached $191.67m , beating expectations by +10.14%.
Earnings released on 21 Feb 2024
EPS came in at -$0.27 falling short of the estimated -$0.23 by -17.39%, while revenue for the quarter reached $196.80m , missing expectations by -2.94%.
Earnings released on 1 Nov 2023
EPS came in at -$0.38 falling short of the estimated -$0.35 by -8.57%, while revenue for the quarter reached $185.62m , missing expectations by -3.68%.
Earnings released on 3 Aug 2023
EPS came in at -$0.30 surpassing the estimated -$0.54 by +44.44%, while revenue for the quarter reached $195.92m , missing expectations by -0.73%.
Earnings released on 3 May 2023
EPS came in at -$0.63 falling short of the estimated -$0.56 by -12.50%, while revenue for the quarter reached $169.38m , missing expectations by -0.50%.
Earnings released on 22 Feb 2023
EPS came in at -$0.01 falling short of the estimated -$0.00 by -338.60%, while revenue for the quarter reached $220.50m , missing expectations by -0.23%.
Earnings released on 2 Nov 2022
EPS came in at -$0.27 falling short of the estimated -$0.05 by -455.33%, while revenue for the quarter reached $204.55m , missing expectations by -1.47%.
Earnings released on 3 Aug 2022
EPS came in at -$0.24 falling short of the estimated -$0.02 by -1.46k%, while revenue for the quarter reached $200.26m , missing expectations by -2.41%.
Earnings released on 4 May 2022
EPS came in at -$0.23 falling short of the estimated -$0.07 by -228.57%, while revenue for the quarter reached $175.91m , beating expectations by +4.57%.
Earnings released on 22 Feb 2022
EPS came in at $0.16 falling short of the estimated $0.21 by -23.81%, while revenue for the quarter reached $210.00m , beating expectations by +5.52%.
Earnings released on 3 Nov 2021
EPS came in at $0.09 surpassing the estimated $0.06 by +50.00%, while revenue for the quarter reached $179.63m , beating expectations by +33.33%.
Earnings released on 4 Aug 2021
EPS came in at $0.06 surpassing the estimated -$0.08 by +175.00%, while revenue for the quarter reached $172.14m , beating expectations by +20.07%.
TNDM Stock Performance
Access detailed TNDM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
